Serum interleukin-17 and estradiol levels in postmenopausal women in relation to osteoporosis

Egyptian Rheumatology and Rehabilitation

Table 1 Comparison between osteoporotic group and non-osteoporotic group regarding demographic data

		Non-osteoporotic group	Osteoporotic group	Test value	P value	Sig.
		No. = 30	No. = 30	Test value	P value	Sig.
Age (years)	Mean ± SD	57.19 ± 6.86	61.44 ± 5.24	−1.909•	0.067	NS
Age (years)	Range	46.6-68.1	51.4-69.9	−1.909•	0.067	NS
Duration of menopause	Mean ± SD	10.00 ± 5.41	12.53 ± 4.17	−1.436•	0.162	NS
Duration of menopause	Range	5-22	6-19	−1.436•	0.162	NS
BMI	Mean ± SD	32.80 ± 5.87	31.60 ± 4.36	0.636•	0.530	NS
BMI	Range	21.5-40.9	23.8-36.7	0.636•	0.530	NS
History of fracture	No	18 (60.0%)	24 (80.0%)	1.429*	0.232	NS
History of fracture	Yes	12 (40.0%)	6 (20.0%)	1.429*	0.232	NS
ADL	Mean ± SD	5.27 ± 0.80	5.07 ± 0.70	0.728•	0.473	NS
ADL	Range	4-6	4-6	0.728•	0.473	NS

P value > 0.05, non-significant; P value ≤ 0.05, significant; P value ≤ 0.01, highly significant independent t test *Chi-square test
BMI body mass index, ADL activities of daily living